Viewing Study NCT03913234


Ignite Creation Date: 2025-12-25 @ 2:37 AM
Ignite Modification Date: 2026-02-25 @ 4:57 PM
Study NCT ID: NCT03913234
Status: UNKNOWN
Last Update Posted: 2022-05-10
First Post: 2019-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase IB & II Study of Ribociclib With Trastuzumab Plus Letrozole in Postmenopausal HR+, HER2+ Advanced Breast Cancer Patients
Sponsor:
Organization: